Literature DB >> 18260803

Sexually active HIV-positive patients frequently report never using condoms in audio computer-assisted self-interviews conducted at routine clinical visits.

Bruce R Schackman1, Zubin Dastur, Quanhong Ni, Mark A Callahan, Judith Berger, David S Rubin.   

Abstract

HIV prevention has become a new priority for HIV clinicians, as their patients live longer and more sexually active lives. Prevention interventions can be effective in clinical settings, but first patients must be screened and inconsistent condom use must be disclosed. Audio computer-assisted self-interviews (ACASI) are an effective way to elicit this sensitive information. We assessed condom use by ACASI among 198 English- or Spanish-speaking HIV patients at 2 community hospital-based HIV clinics in Queens and the Bronx, New York. Among 120 patients reporting sex with a regular partner in the past 4 weeks, 41 (34%) reported not using a condom every time and 22 (18%) reported never using a condom. Among 81 reporting sex with a casual partner in the past 4 weeks, 21 (26%) reported not using a condom every time and 12 (15%) reported never using a condom. Overall, 24 of 129 sexually active patients (19%) reported never using a condom. In a multivariable model controlling for age, race/ethnicity, gender, and HIV exposure category, depression symptoms (Center for Epidemiological Studies Depression Scale [CES-D] score >/= 16; p = 0.03) and self-reported antiretroviral medication non-adherence (</=95% doses in past 3 days; p = 0.03) were significantly associated with never using a condom with a regular or casual partner. ACASI interviews may be an effective way of identifying patients in clinical settings who require prevention counseling as well as other psychosocial services.

Entities:  

Mesh:

Year:  2008        PMID: 18260803     DOI: 10.1089/apc.2007.0037

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  8 in total

1.  Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.

Authors:  Lynn E Taylor; Marisa Holubar; Kunling Wu; Ronald J Bosch; David L Wyles; John A Davis; Kenneth H Mayer; Kenneth E Sherman; Karen T Tashima
Journal:  Clin Infect Dis       Date:  2011-01-31       Impact factor: 9.079

2.  Handheld computers to run ACASI to assess HIV risk and deliver tailored soap opera video feedback: acceptability among young adult urban women.

Authors:  Rachel Jones
Journal:  J Assoc Nurses AIDS Care       Date:  2011-06-12       Impact factor: 1.354

3.  Caregiver role overload and network support in a sample of predominantly low-income, African-American caregivers of persons living with HIV/AIDS: a structural equation modeling analysis.

Authors:  Mary M Mitchell; Amy Knowlton
Journal:  AIDS Behav       Date:  2012-02

4.  Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study.

Authors:  Ramona Bhatia; Christine Hartman; Michael A Kallen; James Graham; Thomas P Giordano
Journal:  AIDS Behav       Date:  2011-08

Review 5.  Secondary prevention of HIV infection: the current state of prevention for positives.

Authors:  Jeffrey D Fisher; Laramie Smith
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

6.  Depression severity is associated with increased risk behaviors and decreased CD4 cell counts.

Authors:  Toshibumi Taniguchi; Enbal Shacham; Nur Fiona Onen; Jessica Rosenbaum Grubb; Edgar Turner Overton
Journal:  AIDS Care       Date:  2014-01-30

7.  Contraceptive use and method preference among HIV-positive women in Amhara region, Ethiopia.

Authors:  Kefyalew Addis Alene; Kendalem Asmare Atalell
Journal:  BMC Womens Health       Date:  2018-06-18       Impact factor: 2.809

8.  Sexual behavior among persons living with HIV in Uganda: implications for policy and practice.

Authors:  Geofrey Musinguzi; Denis Bwayo; Noah Kiwanuka; Sheila Coutinho; Aggrey Mukose; Joseph Kabanda; Lilian Sekabembe; Fred Nuwaha
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.